Literature DB >> 2613931

Effect of adhesive antibiotic TA on plaque and gingivitis in man.

A Manor1, I Eli, M Varon, H Judes, E Rosenberg.   

Abstract

The adhesive antibiotic TA was applied to the dento-gingival junction of 8 human volunteers, suffering from moderate to severe gingivitis. 2 diametrically opposed quadrants of the mouth received 4 applications of 0.1 mg TA, while the other 2 quadrants were treated with a placebo and served as controls. The plaque index, gingival index and bleeding index were scored periodically for 2 weeks and in 4 patients for up to 30 days. The TA-treated quadrants showed a rapid decrease in all 3 indices following 2 treatments. A further improvement was observed with the 3rd and 4th treatments. 30 days after the onset of the experiment and 23 days after the last application, the indices were still considerably lower than the initial values.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613931     DOI: 10.1111/j.1600-051x.1989.tb01029.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  5 in total

Review 1.  Recent advances in the social and developmental biology of the myxobacteria.

Authors:  M Dworkin
Journal:  Microbiol Rev       Date:  1996-03

2.  Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.

Authors:  Yao Xiao; Klaus Gerth; Rolf Müller; Daniel Wall
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

3.  Mutation and mapping of genes involved in production of the antibiotic TA in Myxococcus xanthus.

Authors:  M Varon; N Fuchs; M Monosov; S Tolchinsky; E Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

4.  Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin.

Authors:  Samir Olatunji; Xiaoxiao Yu; Jonathan Bailey; Chia-Ying Huang; Marta Zapotoczna; Katherine Bowen; Maja Remškar; Rolf Müller; Eoin M Scanlan; Joan A Geoghegan; Vincent Olieric; Martin Caffrey
Journal:  Nat Commun       Date:  2020-01-09       Impact factor: 14.919

Review 5.  Mode of action of lipoprotein modification enzymes-Novel antibacterial targets.

Authors:  Simon Legood; Ivo G Boneca; Nienke Buddelmeijer
Journal:  Mol Microbiol       Date:  2020-10-12       Impact factor: 3.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.